The circulating high levels of IL-6 in patients with breast cancer were shown to be positively associated with cancer metastasis and poor survival rate [10,11], consistent with the results of meta-analysis from a Kaplan–Meier Plotter (Figure 4c). Here, IL6 is linked to breast cancer.